CASE STUDIES

We help you understanding patient needs with a customized mix of approaches.

Our greatest passion is learning from patients and partnering with them to capture and share their expertise with professionals in the healthcare system, in particular industry, payers, and HCPs. With every project, our goal is co-creating solutions that benefit both patients and industry..

Co-Creating Clinical Trial Design and Recruitment Strategy

The client needs to obtain the patient view and preferences on clinical trial design.

Understanding the Patient Pathway

The client is beginning to design a clinical trial protocol for a new phase I/II trial in a poorly understood, under diagnosed, and rare genetic disorder.

Enhancing Clinical Trial Recruitment

The client needed assistance recruiting patients for a phase I/II trial in a disease area with many other simultaneously ongoing clinical trials.

Supporting Patient Access to Treatment

For the European Medicines Agency to maintain the Orphan Drug Designation, data was necessary to evaluate the use and access to mexiletine across Europe. There is limited data on the impact of and disrupted availability of mexiletine in the EU.

Developing a Patient Advisory Board

The client would like to establish a European patient advisory board to guide upcoming trials.

Multi-Stakeholder Co-Creation on Real-World Evidence

A client wishes to submit an HTA dossier to a payer institution for a therapeutic indication with many other approved treatments.

Mapping the Patient Landscape

The client is ready to begin engaging with patients for advice on designing a new clinical development program but lacks relationships.

Multimedia Content Creation

The client wants to create content in collaboration with patients and tell their personal stories but can’t get in direct contact.

Improving Patient Information and Community Building

There are no dedicated support groups in Germany for an ultra-rare disease.

Internal Patient Engagement Roadmap Workshop

The client wants to better understand potential future patient engagement activities in a therapeutic indication where they lack prior experience.

*All ideas for illustration only. Any specific recommendations require a detailed confidential discussion with the client. Contact us to get started in that process. We tailor our proposals and services to the needs of each client in a cost-effective manner that upholds patients’ dignity as the first principal.

Co-Creating Clinical Trial Design and Recruitment Strategy

The client needs to obtain the patient view and preferences on clinical trial design.

Understanding the Patient Pathway

The client is beginning to design a clinical trial protocol for a new phase I/II trial in a poorly understood, under diagnosed, and rare genetic disorder.

Enhancing Clinical Trial Recruitment

The client needed assistance recruiting patients for a phase I/II trial in a disease area with many other simultaneously ongoing clinical trials.

Supporting Patient Access to Treatment

For the European Medicines Agency to maintain the Orphan Drug Designation, data was necessary to evaluate the use and access to mexiletine across Europe. There is limited data on the impact of and disrupted availability of mexiletine in the EU.

Developing a Patient Advisory Board

The client would like to establish a European patient advisory board to guide upcoming trials.

Multi-Stakeholder Co-Creation on Real-World Evidence

A client wishes to submit an HTA dossier to a payer institution for a therapeutic indication with many other approved treatments.

*All ideas for illustration only. Any specific recommendations require a detailed confidential discussion with the client. Contact us to get started in that process. We tailor our proposals and services to the needs of each client in a cost-effective manner that upholds patients’ dignity as the first principal.